Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Orphan Status Granted to GW's Cannabis Drug

April 21, 2016 10:23 am | by Ryan Bushey, Digital Editor | Articles | Comments

This disease marks the third treatment indication GW is pursuing.

TOPICS:

Study Finds Explanation for Some Treatment-Resistant Breast Cancers

April 21, 2016 9:45 am | by Vanderbilt University Medical Center | News | Comments

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.

TOPICS:

Risperidone: Increased Appetite, Weight Gain in Children Treated for Autism

April 21, 2016 9:32 am | by Emory University | News | Comments

The drug risperidone has been successful in reducing serious behavioral problems in children with autism spectrum disorder (ASD), but researchers have discovered that increased appetite, followed by weight gain, can be a undesirable adverse effect. 

TOPICS:
Advertisement

Cancer Survival Rates Could Increase with Aspirin Regimen

April 21, 2016 8:34 am | by Cardiff University | News | Comments

The team’s review looked at all of the available data including five randomized trials and forty two observational studies of colorectal, breast and prostate cancers.

TOPICS:

Research Could Expand Engineered T-Cell Cancer Treatment

April 21, 2016 8:30 am | by Purdue University | News | Comments

T cells are the immune system's natural defense against cancer and other harmful entities in the human body. 

TOPICS:

Biden Urges Cancer Researchers to Collaborate, Calls for Guidance

April 20, 2016 4:39 pm | by Stephanie Guzowski, Editor | Articles | Comments

Vice President Joe Biden encouraged the nation’s leading cancer researchers to collaborate more effectively and to share data in an effort to accelerate ambitious cancer research goals, at the American Association for Cancer Research annual meeting.

TOPICS:

Targeted Agent to Mitigate Sepsis

April 20, 2016 3:14 pm | by Institute for Basic Science | News | Comments

Sepsis is caused by the immune system severely overreacting to an infection and attacking itself.

TOPICS:

Breakthrough Cholesterol Drugs Fizzle Amid Price Pushback

April 20, 2016 3:04 pm | by Matthew Perrone, AP Health Writer | News | Comments

When a powerful pair of cholesterol-lowering drugs first hit the market last summer, initial excitement in the medical community quickly turned to panic.

TOPICS:
Advertisement

Cellular Trojan Horse Yields Potential Cancer Treatment

April 20, 2016 1:58 pm | by Brigham and Women's Hospital | News | Comments

Prostate cancer tumors are characterized by a mixed cell population, which makes targeting the different kinds of cells with one treatment very difficult.

TOPICS:

Toward a Resistance Proof Antiviral That Can Treat Many Diseases

April 20, 2016 1:53 pm | by American Chemical Society | News | Comments

Scientists and health officials are marshalling forces to fight Zika, the latest in a string of recent outbreaks.

TOPICS:

Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists

April 20, 2016 9:25 am | by American Association for Cancer Research | News | Comments

Stand Up To Cancer (SU2C) announced Monday that it is awarding 10 grants of $750,000 each to early-career scientists to support innovative, high-risk, high-reward projects in cancer research. The announcement was made at the 2016 Annual Meeting of the American Association for Cancer Research, SU2C’s Scientific Partner.

TOPICS:

Slight Increase in Norwegian Drug Consumption in 2015

April 20, 2016 9:10 am | by Norwegian Institute of Public Health | News | Comments

Drug sales measured in defined daily doses (DDD) increased by 2 percent from 2014 to 2015. Revenue growth was 8.6 percent. This is shown in "Drug Consumption in Norway 2011-2015," a report issued by the Norwegian Institute of Public Health.

TOPICS:

NICE Recommends PTC's Duchenne Muscular Dystrophy Drug

April 20, 2016 8:59 am | News | Comments

The drug has been called a ‘step change’ in the management of the disease which causes progressive muscle wasting and is usually fatal by age 30.

TOPICS:

Nanoparticle Acts like Trojan Horse to Halt Asthma

April 20, 2016 8:59 am | by Northwestern University | News | Comments

The technology can be applied to food allergies as well.

TOPICS:

AbbVie, University of Chicago Announce Cancer Research Collaboration

April 20, 2016 8:46 am | News | Comments

Both organizations will work together to advance research in several areas of oncology.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading